Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Bavarian Nordic A/S

+ Add to Watchlist

BVNKF:US

51.0000 USD 1.5000 3.03%

As of 15:50:40 ET on 05/29/2015.

Snapshot for Bavarian Nordic A/S (BVNKF)

Open: 49.7500 Day's Range: 49.7500 - 51.0000 Volume: 5,418
Previous Close: 49.5000 52wk Range: 13.2500 - 53.4000 1-Yr Rtn: +125.17%

Stock Chart for BVNKF

No chart data available.
  • BVNKF:US 51.0000
  • 1D
  • 1M
  • 1Y
49.5000
Interactive BVNKF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BVNKF

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 193.6695
Relative P/E vs. SPX -
Earnings Per Share (DKK) (ttm) -
Est. EPS (DKK) (12/2015) 1.7550
Est. PEG Ratio -
Market Cap (M USD) 1,390.60
Shares Outstanding (M) 27.81
30 Day Average Volume 238
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/25/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BVNKF

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for BVNKF

Bavarian Nordic A/S is a biotechnology company developing and producing vaccines for the treatment and prevention of cancer and infectious diseases. The company also manufactures and delivers modern smallpox vaccines for governments under national emergency rules.

Paul ChaplinPresident/CEOJames B Breitmeyer "Jim"Exec VP/Chief Development Officer
Ole LarsenExec VP/CFORolf Sass SoerensenVP:Investor Relations
More Company Profile & Key Executives for BVNKF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • BVNKF News

  • Industry News

No stories found
No stories found
Advertisement
Sponsored Links
Advertisements
sec ||= nil